Dorner F, McDonel J L
Vaccine. 1985 Jun;3(2):94-102. doi: 10.1016/0264-410x(85)90056-8.
A rebirth of interest and activity in vaccine development has occurred in recent years which is probably due to the persistence of threat to health by infectious diseases, as well as technological advances which have made possible new approaches to solve old problems. Most work being done today with vaccine development against diseases caused entirely or in part by bacterial toxins falls into the categories of, attenuated organisms (whether by classical means or application of newly developed genetic technologies), and/or toxin subunits (derived by genetic manipulations, peptide synthesis, or chemical modification of toxins). This review discusses some of these new approaches in general as well as specific examples of their application to several bacterial diseases whose pathologies involve toxins.
近年来,疫苗研发领域重新引起了人们的关注并开展了相关活动,这可能是由于传染病对健康的威胁持续存在,以及技术进步使得解决旧问题的新方法成为可能。如今,针对完全或部分由细菌毒素引起的疾病进行疫苗研发的大部分工作可分为以下几类:减毒生物体(无论是通过传统方法还是应用新开发的基因技术)和/或毒素亚基(通过基因操作、肽合成或毒素的化学修饰获得)。本综述将总体讨论其中一些新方法,以及它们应用于几种病理学涉及毒素的细菌性疾病的具体实例。